Jason S. Carter - 18 Nov 2024 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Chief Legal Officer
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol
VERA
Transactions as of
18 Nov 2024
Net transactions value
$0
Form type
4
Filing time
20 Nov 2024, 16:07:22 UTC
Next filing
25 Nov 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Award $0 +53,000 $0.000000 53,000 18 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Stock Option (right to buy) Award $0 +108,000 $0.000000 108,000 18 Nov 2024 Class A Common Stock 108,000 $44.81 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under the Issuer's 2024 Inducement Plan. One-fourth of the RSUs vest on each February 20, May 20, August 20 and November 20 following the vesting commencement date of November 18, 2024, subject to the Reporting Person's continuous service through each vesting date.
F2 1/4 of the shares subject to the option vest on November 18, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date.